How Does Vagus Nerve Stimulation Affect Blood Glucose, Food, and Movement Cravings?

Part of paid clinical trials in Duluth, Minnesota.

Sponsor
University of Minnesota
Study ID
NCT07457372
Status
Withdrawn

Conditions

  • Vagus Nerve Stimulation

Eligibility Criteria

Sex
ALL
Age
18 Years - 35 Years
Healthy Volunteers
Accepted

Interventions

  • Active taVNS — DEVICE
    Actual taVNS
  • Sham taVNS — DEVICE
    No nerve stimulation

Study Details

The purpose of this study is to determine the feasibility of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to examine physiological and psychological responses in a college-aged healthy population

Key Dates

First listed
Mar 9, 2026
Start date
Sep 1, 2026
Status verified
Jul 2026
Primary completion
May 1, 2028
Completion
May 1, 2028

Study Design

Enrollment
0 participants (actual)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE

Arms

  • Active Comparator: Active taVNS
  • Placebo Comparator: Sham taVNS

Primary Outcome Measure

Change in plasma glucose [ Time Frame: Hour 2 after oral glucose load ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Minnesota DuluthDuluthMinnesota55812-

Find similar trials in Duluth, MN

By research site
University of Minnesota Duluth· Duluth, MN

Related Studies